Estefanía Cerro-Herreros

miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models

Estefanía Cerro-Herreros, María Sabater-Arcis, Juan M. Fernández‐Costa et al. · Nature Communications · 2018 · 89 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences

Chantal Sellier, Estefanía Cerro-Herreros, Markus Blatter et al. · Nature Communications · 2018 · 77 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 <i>Drosophila</i> model

Ariadna Bargiela, Estefanía Cerro-Herreros, Juan M. Fernández‐Costa et al. · Disease Models & Mechanisms · 2015 · 73 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila

Estefanía Cerro-Herreros, Juan M. Fernández‐Costa, María Sabater-Arcis et al. · Scientific Reports · 2016 · 44 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy

Estefanía Cerro-Herreros, Irene González-Martínez, Nerea Moreno-Cervera et al. · Molecular Therapy — Nucleic Acids · 2020 · 42 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17